Suchergebnisse - "Selle, F"

PubPharm (92)

1

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38) : a phase IIIb trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Pujade-Lauraine, E. | Selle, F. | Scambia, G. | +21

CommentOn: Ann Oncol. 2023 Dec;34(12):1074-1076. - PMID 38072509

2

Olaparib plus bevacizumab first-line maintenance in ovarian cancer : final overall survival results from the PAOLA-1/ENGOT-ov25 trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Ray-Coquard, I. | Leary, A. | Pignata, S. | +28

3

A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery

enthalten in: ESMO open | 2021

von Pautier, P. | Floquet, A. | Chevreau, C. | +19

4

Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer : a randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Pignata, S. | Lorusso, D. | Joly, F. | +62

5

Need for risk-adapted therapy for malignant ovarian germ cell tumors : A large multicenter analysis of germ cell tumors' patients from French TMRG network

enthalten in: Gynecologic oncology | 2020

von Derquin, F. | Floquet, A. | Hardy-Bessard, A. | +29

6

The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study

enthalten in: Gynecologic oncology | 2020

von Lenck, C. | Chopin, N. | Gouy, S. | +27

7

Glassy cell carcinoma of the uterine cervix : An aggressive type of cancer

enthalten in: La Revue de medecine interne | 2019

von Montagner, C. | Bricou, A. | Selle, F. | +9

8

Evaluation of supportive and barrier-protective skin care products in the daily prevention and treatment of cutaneous toxicity during systemic chemotherapy

in: OncoTargets and Therapy | 2018

von Lüftner D | Dell’Acqua V | Selle F | +8

9

Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von Park, S. | Kwok, J. | Asher, R. | +4

CommentIn: Ann Oncol. 2017 Nov 1;28(11):2631-2632. - PMID 28950347

10

Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors : a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von De Giorgi, U. | Richard, S. | Badoglio, M. | +16

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]